|
|
|
| Screening, Cloning and Expression of Esterase Gene for Enantioselective Resolution of (R)-ketoprofen |
| LIU Rui-en, ZHAO Yun-ying, SHI Fei-fei, ZHAO Yu-hong, XU Li-juan, ZHANG Jin-hong |
| College of Life Science, Nankai University, Tianjin 300071, China |
|
|
|
Abstract It was carried out on a Bacillus megaterium NK13 strain which to a certain extent could asymmetricly hydrolyzes the rac-ketoprofen chloroethyl ester to (S)-ketoprofen. By constructing Bacillus megaterium NK13 gene library, one positive clone containing the plasmid pUC18-NK- HYD3 was obtained. The analysis of sequence detection showed that the positive clone included one Open Read Frame of 741 bp nucleotide sequence which contains esterases’ conserved motif —— GXSXG. The results of blast in NCBI database showed that it was a novel esterase gene. Then the esterase gene was cloned to pET-21b(+) vector and transformed into E.coli BL21(DE3). After being induced by IPTG, SDS-PAGE analysis showed that the relative molecular mass of the esterase was about 28 kDa. The results of TLC and HPLC indicated that the esterase is a (R)-ketoprofen enantioselective enzyme. In the recombinant strain suspension system, The highest enantiomeric yield of (R)-ketoprofen was 62.74% when conversion rate was 15%. In PBS system, which contained the recombinant strain wet cells, when the conversion rate increased from 10% to 50%, the e.e.% of (R)-ketoprofen were maintained at 73%~76%.
|
|
Received: 12 June 2010
Published: 25 October 2010
|
|
|
|
Corresponding Authors:
ZHANG Jin-hong
E-mail: jinhzhang@nankai.edu.cn
|
|
|
|
[1] Hutt A J, Caldwell J. The importance of stereochemistry in the clinical pharmacokinetics of the arylpropionic acid non-steroidal anti-inflammatory drugs. Clin Pharmacokin, 1984, 9:371.
[2] Famaey J P, Paulus H E. Therapeutic Applications of NSAIDs. New York: Marcel Dekker, 1992.
[3] Ossipov M H, Jerussi T P, Ren K, et al. Differential effects of spinal (R)-ketoprofen and (S)-ketoprofen against signs of neuropathic pain and tonic nociception: evidence for a novel mechanism of action of (R)-ketoprofen against tactile allodynia. Pain, 2000, 87:193-199.
[4] Wang Y H, Li Q S, Zhang Z M, et al. Solvent effects on the enantio- selectivity of the thermophilic lipase QLM in theresolution of (R,S)-2-octanol and (R,S)-2-pentanol. Journal of Molecular Catalysis B: Enzymatic, 2009, 56(2-3):146-150.
[5] 胡艾希, 曹声春, 董先明, 等. 2-芳基丙酸类消炎药的酶催化拆分研究进展. 中国医药工业杂志, 2001, 6(32): 284-287. Hu A X, Cao S C, Dong X M, et al. Chinese Journal of Pharmaceuticals, 2001, 6(32): 284-287.
[6] Long Z D, Xu J H, Zhao L L, et al. Overexpression of Serratia marcescens lipase in Escherichia coli for efficient bioresolution of racemic ketoprofen. Journal of Molecular Catalysis B: Enzymatic, 2007, 47:105-110.
[7] Lee K W, Shin G S, Bae H A, et al. Isolation and characterization of Acinetobacter sp. ES-1 excreting a lipase with high enantioselectivity for (S)-ketoprofen ethyl ester. Biotechnology Letters, 2004, 26 (21):1639-1642.
[8] Zhang J H, Guan R, Tan Z L, et al. Purification and properties of lipases/esterases from a Bacillus strain for enantioselective resolution of (S)-ketoprofen. Artificial Cells, Blood Substitutes, and Biotechnology, 2005, 33(4):435-445.
[9] Ausubel F, Brent R, Kingston R E, 等. 精编分子生物学实验指南.北京:科学出版社, 2001. Ausubel F, Brent R, Kingston R E, et al. Short Protocols in Molecular Biology. Beijing: Science Press, 2001.
[10] Sambrook J,Russell D. 分子克隆实验指南, 第3版. 北京:科学出版社, 2002. Sambrook J, Russell D. Protocols in Molecular Clone. 3rd ed Beijing: Science Press, 2002.
[11] Jaeger K E, Dijkstra B W, Reetz M T. Bacterial biocatalysts:Molecular Biology, three-dimensional structures and biotechnological applications of lipases. Annu Rev Microbiol, 1999, 53:315-351.
[12] 许丽娟, 谭之磊, 刘刚, 等. NK13中(S)-酮基布洛芬拆分用酯酶基因的克隆及表达. 中国生物工程杂志, 2008, 28 (2):32-36. Xu L J, Tan Z L, Liu G, et al. China Biotechnology. 2008, 28 (2):32-36.
[13] 许丽娟, 赵玉红, 刘瑞恩, 等. (S)-酮基布洛芬拆分用脂肪酶基因的克隆及表达. 生物工程学报, 2010, 26 (1):108-113. Xu L J, Zhao Y H, Liu R E, et al. Chin J Biotech. 2010, 26 (1):108-113.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
